SEC Form D · Amendment · filed November 22, 2023
Neuralink Corp
Offering
$323.2M
Sold
$323.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FREMONT, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗